{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:39:46Z","timestamp":1778668786741,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.prp.2017.12.020","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T18:12:11Z","timestamp":1514916731000},"page":"385-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining"],"prefix":"10.1016","volume":"214","author":[{"given":"Xiao-jiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-shu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah Abdirahman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-quan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.12.020_bib0005","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.18632\/oncotarget.6368","article-title":"Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2017.12.020_bib0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.18632\/oncotarget.1458","article-title":"Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cance","volume":"5","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2017.12.020_bib0015","first-page":"1993","article-title":"Expression and clinical implication of Beclin1, HMGB1, p 62, survivin, BRCA1 and ERCC1 in epithelial ovarian tumor tissues","volume":"20","author":"Ju","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2017.12.020_bib0020","first-page":"313","article-title":"Expression of Survivin and Smac in epithelial ovarian carcinoma and its clinical significance","volume":"42","author":"Ma","year":"2015","journal-title":"J. Int. Oncol."},{"key":"10.1016\/j.prp.2017.12.020_bib0025","first-page":"017","article-title":"Research progress in relationship between survivin gene and ovarian carcinoma","volume":"19","author":"Lu","year":"2013","journal-title":"Med. Recapitulate"},{"key":"10.1016\/j.prp.2017.12.020_bib0030","article-title":"Fish-oil-derived eicosapentaenoic acid decreases survivin expression and induces wt-p53 accumulation with caspase-3 activation in acute lymphoblastic leukemia cells","author":"Sam","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.prp.2017.12.020_bib0035","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3892\/ol.2017.6373","article-title":"Effect of TERT on the growth of fibrosarcoma via caspase-3, survivin and PKB","volume":"14","author":"Ma","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2017.12.020_bib0040","doi-asserted-by":"crossref","first-page":"46060","DOI":"10.1038\/srep46060","article-title":"Dihydromyricetin induces apoptosis and reverses drug resistance in ovarian cancer cells by p53-mediated downregulation of survivin","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2017.12.020_bib0045","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1021\/mp500835z","article-title":"Targeted microbubbles for ultrasound mediated short hairpin RNA plasmid transfection to inhibit survivin gene expression and induce apoptosis of ovarian cancer A2780\/DDP cells","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2017.12.020_bib0050","first-page":"3","article-title":"Research of expression and correlation of Livin and Survivin in ovarian cancer","author":"Liu","year":"2016","journal-title":"China Pract. Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0055","doi-asserted-by":"crossref","first-page":"14259","DOI":"10.1007\/s13277-016-5290-9","article-title":"Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin a novel combination for inhibiting epithelial ovarian cancer cell proliferation","volume":"37","author":"Sankpal","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2017.12.020_bib0060","first-page":"497","article-title":"Expression of Survivin, M M P-2 and P16 protein in ovarian epithelial carcinoma and its clinical significance","author":"Liu","year":"2015","journal-title":"Shaanxi Med. J."},{"key":"10.1016\/j.prp.2017.12.020_bib0065","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/sj.onc.1203429","article-title":"Survivin initiates procaspase 3\/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death","volume":"19","author":"Suzuki","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2017.12.020_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10735-016-9661-8","article-title":"Survivin and cycline D1 expressions are associatedwith malignant potential in mucinous ovarian neoplasms","volume":"47","author":"Kanter","year":"2016","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.prp.2017.12.020_bib0075","first-page":"58439","article-title":"Preclinical study of CC223 as a potential anti-ovarian cancer agent","volume":"8","author":"Jin","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2017.12.020_bib0080","first-page":"30583","article-title":"CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2","volume":"304\u20133835","author":"Xu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2017.12.020_bib0085","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1021\/acs.analchem.7b02934","article-title":"Immuno-matrix-assisted laser desorption\/ionization assays for quantifying AKT1 and AKT2 in breast and colorectal cancer cell lines and tumors","volume":"89","author":"Popp","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.prp.2017.12.020_bib0090","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.3892\/ol.2017.6647","article-title":"MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1","volume":"14","author":"Shi","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2017.12.020_bib0095","article-title":"Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors","volume":"278","author":"Grass","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.prp.2017.12.020_bib0100","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1158\/1078-0432.CCR-17-0901","article-title":"Targeting prostate cancer subtype 1 by forkhead box M1 pathway inhibition","volume":"23","author":"Ketola","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2017.12.020_bib0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/CAD.0b013e3283454526","article-title":"An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignancies","volume":"22","author":"Spaniol","year":"2011","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.prp.2017.12.020_bib0110","first-page":"773","article-title":"Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors","volume":"15","author":"Sui","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2017.12.020_bib0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-0463.2008.00003.x","article-title":"The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters","volume":"117","author":"Lin","year":"2009","journal-title":"Apmis Acta Pathol. Microbiol. Et Immunol. Scand."},{"key":"10.1016\/j.prp.2017.12.020_bib0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/IGC.0b013e31827ad2b8","article-title":"Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer","volume":"23","author":"Chen","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2017.12.020_bib0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00404-013-3000-z","article-title":"Prognostic importance of survivin, Ki-67, and topoisomerase II\u03b1 in ovarian carcinoma","volume":"289","author":"Kucukgoz","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.prp.2017.12.020_bib0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5146\/tjpath.2014.01162","article-title":"Demir, correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas","volume":"30","author":"\u00c7abuk","year":"2014","journal-title":"Turk. J. Pathol."},{"key":"10.1016\/j.prp.2017.12.020_bib0135","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1007\/s13277-015-3050-x","article-title":"Prognostic significance of pretreatment VEGF, survivin, and Smac\/DIABLO serum levels in patients with serous ovarian carcinoma","volume":"36","author":"Dobrzycka","year":"2015","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.22426","article-title":"Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma","volume":"109","author":"Kleinberg","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2017.12.020_bib0145","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-015-1553-x","article-title":"Overexpression of Class III \u03b2-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer","volume":"15","author":"Du","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2017.12.020_bib0150","first-page":"2746","article-title":"Expression and significance of Survivin and COX- 2 in ovarian","volume":"31","author":"Wang","year":"2009","journal-title":"Hebei Med. J."},{"key":"10.1016\/j.prp.2017.12.020_bib0155","first-page":"173","article-title":"Expression of survivin in ovarian epithelial carcinoma and its correlation with expression of Fas and FasL","volume":"23","author":"Ma","year":"2004","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.prp.2017.12.020_bib0160","first-page":"215","article-title":"Survivin expression in ovarian carcinoma","volume":"37","author":"Yin","year":"2006","journal-title":"J. Sichuan Univ. Med. Sci. Ed."},{"key":"10.1016\/j.prp.2017.12.020_bib0165","first-page":"3009","article-title":"Expression of PTEN and survivin in ovarian epithelial neoplasms","volume":"25","author":"Zhu","year":"2009","journal-title":"J. Pract. Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0170","first-page":"29","article-title":"Expression of survivin protein in epithelial ovarian cancer tissues and its significance","volume":"37","author":"Liu","year":"2014","journal-title":"Heilongjiang Med. Pharm."},{"key":"10.1016\/j.prp.2017.12.020_bib0175","first-page":"52","article-title":"Expression and significance of Survivin, NF-KBp65 and IKB-\u03b1 in epithelial ovarian tumors","volume":"15","author":"Deng","year":"2015","journal-title":"World Latest Med. Inf."},{"key":"10.1016\/j.prp.2017.12.020_bib0180","series-title":"Expression and Significance of Survivin and BAG - 1 in Epithelial Ovarian Cancer","author":"Ren","year":"2007"},{"key":"10.1016\/j.prp.2017.12.020_bib0185","first-page":"372","article-title":"Expression of Survivin and Caspase-3 in epithelial ovarian cancer and effection of chemotherapeutics to Survivin and Caspase-3","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Gannanmed. Univ."},{"key":"10.1016\/j.prp.2017.12.020_bib0190","series-title":"The Expression and Significance of Survivin, Caspase. 3 and CyclinD 1 in Epithelial Ovarian Tumors","author":"Lang","year":"2012"},{"key":"10.1016\/j.prp.2017.12.020_bib0195","first-page":"2244","article-title":"Expression and significance of Snail and Survivin in ovarian cancer","volume":"45","author":"Jin","year":"2016","journal-title":"Chongqing Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0200","first-page":"1373","article-title":"The study of expression and significance of p53 and survivin protein levels in ovarian cancer tissue of endometriosis","volume":"16","author":"Lin","year":"2017","journal-title":"J. Clin. Exp. Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0205","first-page":"21","article-title":"Expression and its significance of apoptosis regulatory factors Survivin\uff0cC-Jun and NF-kB in ovarian epithelial tumors","volume":"52","author":"Li","year":"2014","journal-title":"China Mod. Doctor"},{"key":"10.1016\/j.prp.2017.12.020_bib0210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PAI.0b013e3181e30dcd","article-title":"Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma","volume":"19","author":"Qian","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2017.12.020_bib0215","first-page":"1029","article-title":"Expression and correlation of nuclear factor-kappa B and survivin in epithelial ovarian tumor","volume":"26","author":"Wang","year":"2005","journal-title":"J. Fourth Mil. Med. Univ."},{"key":"10.1016\/j.prp.2017.12.020_sbref0220a","first-page":"65","article-title":"Correlation and significance of survivin and VEGF \u2013 C protein expression in epithelial ovarian cancer","volume":"24","author":"Long","year":"2015","journal-title":"Prog. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2017.12.020_sbref0220b","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000316049","article-title":"Quantitative detection of serum survivin and its relationship with prognostic factors in ovarian cancer","volume":"71","author":"No","year":"2011","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.prp.2017.12.020_bib0225","series-title":"Significance and Prognostic Studies of Survivin, CD105, and Ki67 Combined Expression in Epithelial Ovarian Cancer","author":"Gu","year":"2016"},{"key":"10.1016\/j.prp.2017.12.020_bib0230","first-page":"315","article-title":"Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors","volume":"21","author":"Sui","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2017.12.020_bib0235","first-page":"121","article-title":"Survivin expression in ovarian cancer","volume":"29","author":"Liguang","year":"2007","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.prp.2017.12.020_bib0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.prp.2007.11.004","article-title":"The prognostic significance of COX-2 and survivin expression in ovarian cancer","volume":"204","author":"Athanassiadou","year":"2008","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2017.12.020_bib0245","series-title":"Wenzhou Medical Scholl","article-title":"Research on the expression of Atk and Survivin proteins in epltbellal ovarian cancer and its clinical significance","author":"Chen","year":"2009"},{"key":"10.1016\/j.prp.2017.12.020_bib0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1757-2215-4-20","article-title":"Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients","volume":"4","author":"Felisiak-Golabek","year":"2011","journal-title":"J. Ovar. Res."},{"key":"10.1016\/j.prp.2017.12.020_bib0255","first-page":"4812","article-title":"Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose regulates apoptosis in ovarian cancer cells via p38 MAPK\/JNK signaling pathway","volume":"8","author":"Zhu","year":"2016","journal-title":"Am. J. Transl Res."},{"key":"10.1016\/j.prp.2017.12.020_bib0260","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1159\/000447926","article-title":"A double-negative feedback interaction between microRNA-29b and DNMT3A\/3B contributes to ovarian cancer progression","volume":"39","author":"Teng","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2017.12.020_bib0265","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1159\/000447797","article-title":"A blockade of IGF signaling sensitizes human ovarian cancer cells to the anthelmintic niclosamide-induced anti-proliferative and anticancer activities","volume":"39","author":"Deng","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2017.12.020_bib0270","first-page":"537","article-title":"Survivin, bcl-2 and matrix metalloproteinase-2 anhance progression of clear cell and serous type ovarian carcinoma","volume":"19","author":"Yoshida","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2017.12.020_bib0275","first-page":"211","article-title":"Expression of survivin is associated with malignant potential in epithelial ovarian carcionma","volume":"10","author":"Takai","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0280","first-page":"79","article-title":"Expression of survivin and CD105 in ovarian cancer and its relationship with chemoresistance and prognosis","volume":"38","author":"Ban","year":"2011","journal-title":"Chin. J. pract. Med."},{"key":"10.1016\/j.prp.2017.12.020_bib0285","first-page":"24","article-title":"Expression of survivin in ovarian cancer in relation to response to chemotherapy and overall survival","volume":"11","author":"Li","year":"2009","journal-title":"Mod. Med. J. China."},{"key":"10.1016\/j.prp.2017.12.020_bib0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000316049","article-title":"Quantitative detection of serum survivin and its relationship with prognostic factors in ovarian cancer","volume":"71","author":"No","year":"2011","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.prp.2017.12.020_bib0295","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.MP.0000073868.31297.B0","article-title":"Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis","volume":"16","author":"Cohen","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2017.12.020_bib0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bjc.6602332","article-title":"Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters","volume":"92","author":"Ferrandina","year":"2005","journal-title":"Br. J. Cancer."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817311093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817311093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T03:59:57Z","timestamp":1603598397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817311093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0344033817311093"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.12.020","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}